Related Experiment Videos
Interaction between ATP and catecholamines in stimulation of platelet aggregation
Alex V Birk1, Endri Leno, Hugh D Robertson
1Department of Pharmacology, Weill Medical College of Cornell University, New York, New York 10021, USA.
American Journal of Physiology. Heart and Circulatory Physiology
|October 22, 2002
Summary
Adenosine triphosphate (ATP) enhances platelet aggregation response to catecholamines like norepinephrine. This interaction, mediated by P2Y1 receptors, suggests ATP may promote blood clot formation during stress.
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Platelets release various substances upon activation, including adenosine triphosphate (ATP) and catecholamines.
- While ATP's role in augmenting norepinephrine's effects in other systems is known, its interaction with catecholamines in platelet regulation was unexplored.
Purpose of the Study:
- To investigate the potential interaction between ATP and catecholamines in regulating human platelet reactivity.
- To determine if ATP modulates platelet aggregation induced by specific catecholamines and serotonin.
Main Methods:
- Human platelet-rich plasma was treated with ATP and various agonists.
- Platelet aggregation, intracellular calcium release, and receptor antagonist effects were measured.
- Selective P2Y1 and P2X1 receptor agonists and antagonists were utilized.
Main Results:
- ATP (1-5 microM) alone did not induce platelet aggregation but potentiated responses to norepinephrine and epinephrine.
- This potentiation was dose-dependent, not due to ADP, and blocked by a P2Y1 receptor antagonist.
- ATP enhanced norepinephrine-induced intracellular calcium release, while P2X1 agonists had no effect.
Conclusions:
- ATP synergistically interacts with norepinephrine to enhance platelet aggregation, primarily via P2Y1 receptors.
- This interaction suggests a prothrombotic role for ATP, particularly in stress-related conditions.
- Further research into ATP-catecholamine signaling in platelets is warranted for clinical implications.